Legal Representation
Attorney
Patricia Lawrence-Kolaras, Esq.
USPTO Deadlines
Next Deadline
39 days remaining
Non-Final Action E-Mailed
Due Date
February 05, 2026
Extension Available
Until May 05, 2026
Application History
8 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 5, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 5, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 5, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Nov 5, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 27, 2025 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Oct 27, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 17, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Jun 17, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Advertising and marketing consultancy; Advertising consultation; Brand imagery consulting services; Branding services, namely, consulting, development, management and marketing of brands for businesses and/or individuals; Business administration consultancy; Business advisory services, consultancy and information; Business and management consulting for healthcare providers and related businesses; Business consultancy; Business consultancy services; Business consultation; Business consultation and management regarding marketing activities and launching of new products; Business consultation services; Business consulting and business information for enterprises; Business management and consulting services for the health care industry, namely, customer service, accounting services, and marketing services; Business management and consulting services for the health care industry, namely, providing industry expertise and supplier partnerships; Business services provided to the healthcare industry, namely, the collection, reporting, and analysis of healthcare quality data for business purposes; Consulting services in the field of medical product approval for commercial purposes; Pharmaceutical cost management services and drug utilization review services; Promoting the exchange of information and resources within the scientific research and medical communities to achieve advances in the field of healthcare
First Use Anywhere:
20130500
First Use in Commerce:
20130500
Additional Information
Design Mark
The mark consists of The stylized letters "ie." with a dot below the letter "i" in blue.
Color Claim
The color(s) blue is/are claimed as a feature of the mark.
Pseudo Mark
IE
Classification
International Classes
035